Quantcast

Latest Macular degeneration Stories

2014-07-11 12:24:38

Funding Critical on Diseases Now Affecting Baby Boomers CLARKSBURG, Md., July 11, 2014 /PRNewswire/ -- BrightFocus Foundation, a nonprofit organization funding cutting-edge, innovative research on Alzheimer's disease and the vision diseases of glaucoma and macular degeneration, today announced the recipients of new research grant awards, offered to 55 scientists in 19 U.S. states, the District of Columbia, and five foreign countries. With these latest grants, BrightFocus has now...

2014-07-09 08:28:58

First clinical trial of integrated approach underlines need for inclusion of behavior activation therapy in low vision rehabilitation SAN FRANCISCO, July 9, 2014 /PRNewswire-USNewswire/ -- The first clinical trial to examine integrated low vision and mental health treatment has shown that the approach can reduce the incidence of depression by half among people with low vision due to age-related macular degeneration (AMD). The results of the study were published online today in Ophthalmology,...

2014-07-07 23:03:18

Dr. Ramin Rabbani, optometrist in Los Angeles, now offering optical exams for complete eye are of his patients. Los Angeles, CA (PRWEB) July 07, 2014 Los Angeles eye doctor, Dr. Ramin Rabbani, is now offering comprehensive optical exams. Routine eye exams can be one of the best ways to preserve eye health and vision. When eye problems are diagnosed early, treatment can often delay or reduce the risk of the condition deteriorating and further damaging vision. Visit his Los Angeles eye...

2014-07-01 23:01:42

Diopsys® NOVA-ERG provides a way to discriminate between AMD and healthy eyes. Pine Brook, NJ (PRWEB) July 01, 2014 In a controlled clinical study, a team of researchers from New York Eye and Ear Infirmary concluded that test data from the Diopsys® NOVA-ERG vision test provides a way to discriminate both dry and wet Age-Related Macular Degeneration (AMD) eyes from healthy eyes. The study results published in a poster titled 'Steady State Pattern Electroretinography (ssPERG)...

2014-06-30 04:21:34

Professor Eberhart Zrenner Discusses the Future of Artificial Vision at Premier International Ophthalmology Meeting PARIS, June 30, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, Retina Implant's co-founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of Tuebingen, Germany, presented...

2014-06-27 08:24:46

TARRYTOWN, N.Y., June 27, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA(®) (aflibercept) Injection has been recommended for approval by the European Committee for Medicinal Products for Human Use (CHMP) for the treatment of visual impairment due to diabetic macular edema (DME). The decision of the European Commission is expected in the second half of 2014. "Diabetes is a growing health concern worldwide and this milestone brings us...

2014-06-26 08:29:02

First population-based study to show that environmental factors may outweigh genetics in myopia development; researchers suggest students should spend time outdoors SAN FRANCISCO, June 26, 2014 /PRNewswire-USNewswire/ -- German researchers have found strong evidence that attaining a higher level of education and spending more years in school are two factors associated with a greater prevalence and severity of nearsightedness, or myopia. Published online this month in Ophthalmology, the...

2014-06-24 08:32:41

MENLO PARK, Calif., June 24, 2014 /PRNewswire/ -- ForSight VISION5 is pleased to announce that Charles Semba, MD has joined the company as Chief Medical Officer from Shire Pharmaceuticals where he served as Vice President, Clinical Medicine (Ophthalmology). ForSight VISION5 is developing non-invasive drug delivery products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy....

2014-06-21 08:20:25

Foundation Fighting Blindness Co-Founder and Chairman Gordon Gund and Family to Catalyze Retinal Degenerative Disease Research with Unlimited Donation Matching Challenge for Two Years COLUMBIA, Md., June 21, 2014 /PRNewswire/ -- In support of the fight to eradicate blindness, Foundation Fighting Blindness Chairman and Co-Founder Gordon Gund and his family announced a matching gift challenge they hope will result in millions of dollars in funds to accelerate pre-clinical,...

2014-06-19 08:28:14

SOPHIA ANTIPOLIS, France, and SAN DIEGO, June 19, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, and Sequenom, Inc. (NASDAQ:SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Nicox's subsidiary, Nicox Inc. is launching expanded access to Sequenom Laboratories' RetnaGene(TM) portfolio of laboratory-developed genetic tests in the United States (U.S.). The RetnaGene portfolio includes...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.